NWAM LLC’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.95M | Sell |
16,900
-26
| -0.2% | -$9.27K | 0.34% | 77 |
|
|
2025
Q4 | $5.9M | Buy |
16,926
+1,106
| +7% | +$351K | 0.33% | 73 |
|
|
2025
Q3 | $4.78M | Buy |
15,820
+495
| +3% | +$144K | 0.26% | 97 |
|
|
2025
Q2 | $4.51M | Buy |
15,325
+898
| +6% | +$254K | 0.26% | 95 |
|
|
2025
Q1 | $4.49M | Sell |
14,427
-146
| -1% | -$43.1K | 0.39% | 55 |
|
|
2024
Q4 | $3.8M | Sell |
14,573
-2,654
| -15% | -$787K | 0.23% | 96 |
|
|
2024
Q3 | $5.55M | Buy |
17,227
+196
| +1% | +$64.1K | 0.34% | 64 |
|
|
2024
Q2 | $5.32M | Buy |
17,031
+2,230
| +15% | +$655K | 1.56% | 12 |
|
|
2024
Q1 | $4.43M | Buy |
14,801
+340
| +2% | +$99.5K | 0.36% | 59 |
|
|
2023
Q4 | $4.17M | Sell |
14,461
-11
| -0.1% | -$3K | 0.33% | 73 |
|
|
2023
Q3 | $3.89M | Sell |
14,472
-287
| -2% | -$71.6K | 0.39% | 59 |
|
|
2023
Q2 | $3.28M | Buy |
14,759
+651
| +5% | +$151K | 0.27% | 90 |
|
|
2023
Q1 | $3.41M | Sell |
14,108
-865
| -6% | -$212K | 0.35% | 79 |
|
|
2022
Q4 | $3.93M | Sell |
14,973
-110
| -0.7% | -$29.5K | 0.35% | 79 |
|
|
2022
Q3 | $3.4M | Buy |
15,083
+433
| +3% | +$105K | 0.32% | 74 |
|
|
2022
Q2 | $3.61M | Sell |
14,650
-5,200
| -26% | -$1.27M | 0.33% | 70 |
|
|
2022
Q1 | $4.8M | Buy |
19,850
+522
| +3% | +$120K | 0.37% | 68 |
|
|
2021
Q4 | $4.35M | Buy |
19,328
+13,788
| +249% | +$2.91M | 0.34% | 67 |
|
|
2021
Q3 | $1.18M | Buy |
5,540
+518
| +10% | +$119K | 0.11% | 199 |
|
|
2021
Q2 | $1.22M | Buy |
5,022
+493
| +11% | +$121K | 0.11% | 183 |
|
|
2021
Q1 | $1.13M | Sell |
4,529
-192
| -4% | -$45.8K | 0.11% | 186 |
|
|
2020
Q4 | $1.09M | Buy |
+4,721
| New | +$1.09M | 0.12% | 165 |
|
|
2020
Q3 | – | Sell |
-4,345
| Closed | -$1.02M | – | 257 |
|
|
2020
Q2 | $1.02M | Sell |
4,345
-130
| -3% | -$29.7K | 0.14% | 143 |
|
|
2020
Q1 | $907 | Buy |
4,475
+445
| +11% | +$97.2K | 0.02% | 158 |
|
|
2019
Q4 | $971K | Buy |
4,030
+77
| +2% | +$17K | 0.17% | 126 |
|
|
2019
Q3 | $765K | Sell |
3,953
-460
| -10% | -$88.3K | 0.14% | 153 |
|
|
2019
Q2 | $813K | Buy |
4,413
+71
| +2% | +$12.7K | 0.16% | 133 |
|
|
2019
Q1 | $825K | Buy |
4,342
+441
| +11% | +$84.2K | 0.18% | 122 |
|
|
2018
Q4 | $759K | Sell |
3,901
-539
| -12% | -$105K | 0.2% | 123 |
|
|
2018
Q3 | $920K | Sell |
4,440
-142
| -3% | -$28K | 0.21% | 108 |
|
|
2018
Q2 | $846K | Buy |
4,582
+88
| +2% | +$15.6K | 0.2% | 113 |
|
|
2018
Q1 | $766K | Sell |
4,494
-1,578
| -26% | -$290K | 0.19% | 121 |
|
|
2017
Q4 | $1.06M | Sell |
6,072
-788
| -11% | -$139K | 0.27% | 91 |
|
|
2017
Q3 | $1.28M | Sell |
6,860
-51
| -0.7% | -$9.04K | 0.33% | 75 |
|
|
2017
Q2 | $1.19M | Buy |
6,911
+2,825
| +69% | +$459K | 0.21% | 73 |
|
|
2017
Q1 | $670K | Sell |
4,086
-179
| -4% | -$29.7K | 0.2% | 113 |
|
|
2016
Q4 | $624K | Buy |
4,265
+1,173
| +38% | +$177K | 0.21% | 122 |
|
|
2016
Q3 | $516K | Buy |
3,092
+156
| +5% | +$26.4K | 0.04% | 132 |
|
|
2016
Q2 | $447K | Sell |
2,936
-590
| -17% | -$91.7K | 0.18% | 123 |
|
|
2016
Q1 | $529K | Sell |
3,526
-60
| -2% | -$8.91K | 0.21% | 110 |
|
|
2015
Q4 | $582K | Buy |
3,586
+586
| +20% | +$92.1K | 0.24% | 100 |
|
|
2015
Q3 | $466K | Sell |
3,000
-1,000
| -25% | -$158K | 0.39% | 58 |
|
|
2015
Q2 | $541K | Buy |
4,000
+470
| +13% | +$75.3K | 0.23% | 106 |
|
|
2015
Q1 | $564K | Sell |
3,530
-692
| -16% | -$109K | 0.24% | 104 |
|
|
2014
Q4 | $673K | Sell |
4,222
-2,795
| -40% | -$436K | 0.29% | 91 |
|
|
2014
Q3 | $986K | Sell |
7,017
-1,101
| -14% | -$144K | 0.35% | 74 |
|
|
2014
Q2 | $961K | Buy |
8,118
+2,299
| +40% | +$266K | 0.3% | 90 |
|
|
2014
Q1 | $718K | Buy |
5,819
+2,932
| +102% | +$356K | 0.25% | 102 |
|
|
2013
Q4 | $329K | Sell |
2,887
-289
| -9% | -$32.9K | 0.17% | 120 |
|
|
2013
Q3 | $355K | Sell |
3,176
-427
| -12% | -$46.3K | 0.17% | 116 |
|
|
2013
Q2 | $355K | Buy |
+3,603
| New | +$374K | 0.18% | 113 |
|
Other funds holding AMGN
VCM
VPM
NWAM LLC's AMGN Position: Q1 2026 in Review
NWAM LLC reduced its Amgen (AMGN) stake by 0.15% in Q1 2026, selling an estimated $9.27K and leaving 16,900 shares worth $5.95M. The position accounts for 0.34% of the portfolio, ranked #77.
NWAM LLC first reported a position in AMGN in Q2 2013 and has held it in 51 quarters since. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- NWAM LLC held 16,900 shares of Amgen worth $5.95M as of Q1 2026.
- NWAM LLC sold 26 Amgen shares in Q1 2026, an estimated $9.27K.
- Amgen made up 0.34% of NWAM LLC's portfolio in Q1 2026, its #77 holding.
- NWAM LLC first reported a position in Amgen in Q2 2013 and has held it in 51 quarters since.
- 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on NWAM LLC's 13F filing for Q1 2026, filed 4 May 2026.